Acquisition Represents Significant Opportunity for Growth in Prescription Dry Eye Segment Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading...
Only Eye Vitamin That Supports Two Health Benefits in One, Clinically Proven AREDS 2 Formula for Eye Health and 100 mg of CoQ10 Antioxidant for...
A Total of 11 Poster Presentations Will Be Presented, Including Data from Two Pivotal Phase 3 Trials and 12-Month Safety Extension Trial of...
First and Only Preservative-Free Contact Lens Rehydrating Drop in a Multi-Dose Bottle Provides Up to Eight Hours of Moisture* For Dry Contact...
New Multifocal Daily Disposable Lens Provides Clear Vision at All Distances, All-Day Comfort and Helps Minimize Contact Lens Dryness Bausch...
Exhibit 99.1 Investor Contacts: Media Contacts: Allison Ryan...
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people...
MIEBO is the First and Only Prescription Eye Drop Approved for Dry Eye Disease that Directly Targets Tear Evaporation, Based on Consistent...
FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...
000186074212/312023Q1FALSEBausch & Lomb CorpP6MP4Y33.3333.3333.3300018607422023-01-012023-03-3100018607422023-04-28xbrli:shares00018607422023-0...
0001860742FALSEBausch & Lomb Corp00018607422022-11-022022-11-02UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM...
Revenues of $931 Million GAAP Net Loss Attributable to Bausch + Lomb Corporation of $90 Million Adjusted EBITDA (non-GAAP)1 of $141 Million...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.